Evidence map›Paper›PMID 38992919›Full record

ArticleCancer science2024

Estimation of self-funded human papillomavirus vaccine recipients from Japan's previously assumed "unvaccinated generation".

Mariya Kobayashi, Satoshi Nakagawa, Yutaka Ueda, Asami Yagi, Mamoru Kakuda, Kosuke Hiramatsu, Tadashi Kimura

Abstract read
In one paragraph

Article in Cancer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mariya KobayashiDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Osaka, Suita-City, Osaka, Japan.ORCID https://orcid.org/0000-0002-3658-4541
Satoshi NakagawaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Osaka, Suita-City, Osaka, Japan.ORCID https://orcid.org/0000-0001-6540-9040
Yutaka UedaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Osaka, Suita-City, Osaka, Japan.ORCID https://orcid.org/0000-0001-8760-6379
Asami YagiDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Osaka, Suita-City, Osaka, Japan.ORCID https://orcid.org/0000-0002-3222-5963
Mamoru KakudaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Osaka, Suita-City, Osaka, Japan.ORCID https://orcid.org/0000-0003-2768-8848
Kosuke HiramatsuDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Osaka, Suita-City, Osaka, Japan.ORCID https://orcid.org/0000-0001-7569-7875
Tadashi KimuraDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Osaka, Suita-City, Osaka, Japan.ORCID https://orcid.org/0000-0003-1279-9078

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise vaccination data is essential to accurately estimate the effectiveness of the human papillomavirus (HPV) vaccine against HPV-related cancers. In Japan, the number of subsidized HPV vaccinations can be tracked through registries, but the number of self-funded vaccinations has not been tracked. The number of individuals who chose to receive the vaccine at their own expense, despite being ineligible for public subsidies due to their age, is unknown and has been nominally considered to be zero. Our aim is to produce a more accurate estimate of this number using recently released proprietary data. First, we estimated the total number of self-funded HPV vaccinations occurring from 2010 to 2012 using public data from the Ministry of Health, Labour and Welfare and our previously reported data on the number of HPV vaccinations eligible for public subsidy. Second, using proprietary data from the vaccine manufacturer, we calculated the distribution of self-funded vaccination shots by age. Finally, we combined these data to estimate the number of self-funded HPV vaccinations by birth fiscal year (FY) relative to a yearly reference population. We found that 78,264 individuals born in FY1993 and 58,190 born in FY1992 self-funded their vaccinations, representing 13.6% and 10.0% of the reference population, respectively. Additionally, we found that 5%-10% of individuals born from FY1986 to FY1991 self-funded their vaccinations. Our study revealed for the first time that a certain number of individuals from the "HPV unvaccinated generation," ineligible for subsidies due to age restrictions, chose to self-fund their vaccinations.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesVaccinationAdolescentAdultChildFemaleHumansJapanMaleMiddle AgedUnvaccinated PersonsYoung AdultPapillomavirus Vaccinescervical cancerepidemiologyestimation technicsHPV vaccineunvaccinated persons

Identifiers

PMID38992919
PMCPMC11462977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.